73,95 €
73,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
37 °P sammeln
73,95 €
73,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
37 °P sammeln
Als Download kaufen
73,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
37 °P sammeln
Jetzt verschenken
73,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
37 °P sammeln
  • Format: PDF

This book provides detailed information on the prevalence and manifestations of the most important oral complications associated with different drug treatments, focusing especially on recently developed therapies. Among the diverse adverse drug reactions covered are gingival overgrowth, ulcerations, lichenoid reactions, pigmentation, and bullous reactions. The potential direct toxic effects on bone of drugs that prevent bone mass loss, such as bisphosphonates and denosumab, are fully examined, as is the occurrence of spontaneous oral bleeding in patients receiving antithrombotic therapies.…mehr

Produktbeschreibung
This book provides detailed information on the prevalence and manifestations of the most important oral complications associated with different drug treatments, focusing especially on recently developed therapies. Among the diverse adverse drug reactions covered are gingival overgrowth, ulcerations, lichenoid reactions, pigmentation, and bullous reactions. The potential direct toxic effects on bone of drugs that prevent bone mass loss, such as bisphosphonates and denosumab, are fully examined, as is the occurrence of spontaneous oral bleeding in patients receiving antithrombotic therapies. Further chapters focus on drug-induced taste disorders and salivary gland disturbances, including xerostomia, swelling, and hypersalivation. The enhanced risk of oral infections when using chemotherapy and biotherapy is addressed, and the closing chapter examines drug-related perioral and facial complications. This book is a collaborative work that brings together clinicians, surgeons, and specialists in drug safety surveillance. It will be of value for all dental and medical practitioners who encounter these complications in their clinical practice.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Sarah Cousty, DDS, PhD, works at the Dental Faculty and the Centre Hospitalier Universitaire de Toulouse (University Hospital), France, where she is a Professor and Senior Lecturer and Hospital Practitioner in Oral Surgery. In 2002, Dr. Cousty gained a Masters Degree in Biological and Medical Sciences and a Degree in Epidemiology (applied to dental research) at Paul Sabatier University in Toulouse. She went on to obtain her DDS at the same university in 2004 (First Class Honors, silver medalist) and completed a PhD in Electrical Engineering, Electrotechnical studies and Telecommunications in 2007. She took up her present position in 2008. Sara Laurencin-Dalicieux, DDS, PhD, works at the Dental Faculty and the Centre Hospitalier Universitaire de Toulouse (University Hospital), France, where she is a Senior Lecturer and Hospital Practitioner in Periodontology. In 2003, Dr. Laurencin-Dalicieux completed a Masters Degree in Biological and Medical Sciences and her DDS(First Class Honors, bronze medalist) at Paul Sabatier University in Toulouse. She gained a PhD in Biology, Health and Biotechnologies and a Degree in Periodontology from the same university in 2010 and 2011, respectively. She took up her current position in 2013. Both authors are in currently charge of the multidisciplinary oral mucosa consultation in Toulouse's University Hospital which interracts and finds itself at the crossroad of other medical specialties such as Dermatology, Maxillo-facial Surgery, ENT and Internal Medicine.